Moleculin Biotech, Inc.
MBRX
$7.59
$0.9614.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.99M | -26.13M | -22.81M | -21.35M | -29.73M |
| Total Depreciation and Amortization | 112.00K | 122.00K | 125.00K | 126.00K | 130.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.71M | 2.72M | -884.00K | -2.87M | 3.53M |
| Change in Net Operating Assets | -278.00K | 1.95M | 1.86M | 231.00K | 2.40M |
| Cash from Operations | -22.45M | -21.34M | -21.71M | -23.86M | -23.68M |
| Capital Expenditure | 0.00 | 0.00 | -13.00K | -13.00K | -94.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -13.00K | -13.00K | -94.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.80M | 18.08M | 12.66M | 4.66M | 8.62M |
| Repurchase of Common Stock | 0.00 | -1.00K | -26.00K | -26.00K | -26.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 19.80M | 18.08M | 12.63M | 4.64M | 8.59M |
| Foreign Exchange rate Adjustments | -48.00K | -28.00K | -20.00K | -32.00K | 7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.70M | -3.29M | -9.11M | -19.27M | -15.17M |